Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care

/in , /by

Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing and to bring improved insights to patients with breast cancer globally SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for […]

Read more →

Illumina collaborates with Nashville Biosciences to accelerate medicines development

/in , /by

Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using […]

Read more →

Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership

/in , /by

SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer. The partnership spans current and future CDx programs, with plans […]

Read more →

Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference

/in , , , /by

Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed today the company’s strong growth trajectory, including 2021 […]

Read more →

SINGULAR GENOMICS PARTNERS WITH LEXOGEN TO ENABLE RNA LIBRARY PREP FOR THE G4 SEQUENCING PLATFORM

/in , , , , , /by

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH LEXOGEN’S EXPERTISE IN RNA LIBRARY PREPARATION KITS TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to […]

Read more →

SINGULAR GENOMICS PARTNERS WITH NEW ENGLAND BIOLABS® TO ENABLE NEBNEXT® KITS FOR THE G4 SEQUENCING PLATFORM

/in , , , , , /by

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE NEBNEXT DNA AND RNA LIBRARY PREP KITS TO EMPOWER HIGH-QUALITY, ESTABLISHED WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with […]

Read more →

SINGULAR GENOMICS PARTNERS WITH TWIST BIOSCIENCE TO ENABLE THE TWIST NGS TARGET ENRICHMENT SOLUTIONS FOR THE G4 SEQUENCING PLATFORM

/in , , , , , /by

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE TWIST TARGET ENRICHMENT SOLUTIONS TO EMPOWER FIXED AND CUSTOM TARGETED SEQUENCING PANELS FOR CUSTOMERS. LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with […]

Read more →

SINGULAR GENOMICS PARTNERS WITH WATCHMAKER GENOMICS TO ENABLE THE WATCHMAKER DNA LIBRARY PREP KITS FOR THE G4 SEQUENCING PLATFORM

/in , , , , , /by

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE WATCHMAKER DNA LIBRARY PREP KITS TO EMPOWER INNOVATIVE WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to […]

Read more →

SINGULAR GENOMICS PARTNERS WITH DOVETAIL GENOMICS TO ENABLE DOVETAIL KITS FOR THE G4 SEQUENCING PLATFORM

/in , , , , , /by

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH DOVETAIL’S EXPERTISE IN 3-D GENOME ARCHITECTURE TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Dovetail Genomics to […]

Read more →

Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service

/in , /by

EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne […]

Read more →